The inability of the unresponsive cancer cells to respond to STING agonists was unlikely due to mutations in the Tmem173 or Mb21d1 genes as nonsynonymous substitutions are not present in either gene in DU145, A549, HeLa and HCT116 cells21, 22. This evidence concerns the gene CGAS and cancer.